Friday 6 November 2026 Export CRSP’s income statement to Excel — free account

CRISPR Therapeutics AG

CRISPR Therapeutics AG’s revenue for fiscal 2025 (year ended December 2025) was $3.5 million, down 90.6% from fiscal 2024.

Revenue: +1,325.1%
EPS: +1.55%
Free cash flow: −6.36%

Quarter to September 2026, against a year earlier

49.92 1.36 +2.80%

Follow CRSP

Alert me

Market cap: $4.7B
P/E: 0.0×
Fwd P/E: −11.8×
Dividend yield: —
F-score: 2/9
Altman Z: 7.04
Beneish M: n/a
Dividend safety: n/a

Overview

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	2	3	2	2	+8 more TTM periods Free account
ROE Full definition →	(25.60%)	(26.09%)	(31.21%)	(30.18%)
ROA Full definition →	(19.00%)	(19.28%)	(23.24%)	(25.81%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(20.29%)	(19.22%)	(23.45%)	(29.79%)
Average Days of Receivables Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(3.89)	(3.85)	(4.18)	(3.85)
Free Cash Flow Full definition →	(376.71)	(371.32)	(401.18)	(345.93)
Capital Expenditures Full definition →	(2.08)	(1.74)	(1.21)	(0.91)
Other line items
Cash ROIC Full definition →	(8.36%)	(7.91%)	(8.29%)	(8.88%)
Accounts Receivable Turnover Full definition →	0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.01	0.01	0.01	0.01
Research and Development Expense of Revenue Full definition →	1,212.81%	2,095.48%	9,192.03%	10,856.38%
Selling, General and Administrative Expense of Revenue Full definition →	282.07%	523.19%	1,740.90%	2,095.21%
Share Based Compensation of Revenue Full definition →	276.80%	510.16%	1,672.22%	2,065.50%
Operating CF/Net income Full definition →	0.82	0.82	0.70	0.59
Depreciation/Fixed assets Full definition →	0.18	0.17	0.17	0.17
Capex/Depreciation Full definition →	(0.11)	(0.09)	(0.06)	(0.05)
Revenue per Share Full definition →	0.26	0.14	0.04	0.04
Operating CF per Share Full definition →	(3.87)	(3.83)	(4.16)	(3.84)
Capex per Share Full definition →	(0.02)	(0.02)	(0.01)	(0.01)
Capex to Sales Full definition →	0.08	0.13	0.30	0.26

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly